Status:
TERMINATED
Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSI
Lead Sponsor:
Solvay Pharmaceuticals
Conditions:
Dyslipidemia
Glucose Metabolism Disorder
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
Under conditions of first-line drug treatment in antidiabetic drug naïve/drug free patients with type 2 diabetes mellitus and dyslipidemia, to show that :- the efficacy of a fixed combination (FC) of ...
Eligibility Criteria
Inclusion
- Patient with Type 2 diabetes mellitus and dyslipidemia inadequately controlled with lifestyle modifications.
Exclusion
- Type 1 diabetes.
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2007
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT00361868
Start Date
June 1 2006
End Date
December 1 2007
Last Update
June 27 2008
Active Locations (70)
Enter a location and click search to find clinical trials sorted by distance.
1
Site105
Pula, Croatia
2
Site102
Rijeka, Croatia
3
Site103
Split, Croatia
4
Site104
Varaždin, Croatia